inVentiv Health Provides Updated Information on December 11th In... ( SOMERSET N.J. Dec. 3 /- inVentiv ...)

inVentiv Health Provides Updated Information on December 11th Investor Day

Date:12/3/2007

SOMERSET, N.J., Dec. 3 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. (Nasdaq: VTIV) today provided updated information on its upcoming Investor Day, which will be held Tuesday, December 11th, 2007 in New York City. The event will be begin at 8:30 a.m., not 9:00 a.m. as announced earlier, and will conclude at noon, followed by lunch.

The agenda will include a business overview, presentations by the leaders of each of the four major divisions, and a look at inVentiv's growing focus on integrated services.

The event will be held at the offices of inVentiv's Chandler Chicco Agency (CCA) business unit, located at 450 West 15th Street, Suite #700 in New York City. Please go to http://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88K I95 6 to request an invitation. Those who do not have Internet access can call (732) 537-4804.

The meeting is open to analysts and investors and will be accessible by live audio webcast on inVentiv Health's website at http://www.inventivhealth.com/health/newsroom/webcasts.asp. Presentation slides also will be available for all participants and an archived version of the webcast will be available on inVentiv Health's website for one week following the presentation.

Webcast segments will include:

8:30 a.m. - 10:30 a.m. Overview and Divisional Presentations

11 a.m. - noon Integrated Opportunities, Summary and Discussion

To listen to the presentation live, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). A
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
2. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
3. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
4. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
5. inVentiv Health Creates Client Development and Integration Team
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Air pollution linked to cardiovascular risk indices in healthy young adults
9. More proof needed of safety and quality of electronic personal health records
10. Health care incentive model offers collaborative approach
11. Loneliness is bad for your health

Post Your Comments:

(Date:12/2/2009)... Award-winning author James...l-length book, Short White Coat: Lessons from Pati...th through the third year of medical school--the g...PHILADELPHIA, PA (PRWEB) December 2, 2009 -- Most...d themselves dressed in a tiny hospital gown or st...

(Date:12/2/2009)..., , SAN DIEGO, Dec. 2 /PRNewswire-FirstCall...present at the 21st Annual Piper Jaffray Health Ca... presentation is scheduled to be webcast live and ...ction of Gen-Probe,s website at www.gen-probe.com...wing the event. ,, About Gen-Probe ,, Gen...

(Date:12/2/2009)..., , JOHANNESBURG, Dec. 2 Le...(over US$6 million) investment in AllLife, the inn...g with HIV and diabetes. The investment brings tog...ent fund, and AllLife, one of Africa,s most innova...lace after World AIDS Day. ,, "AllLife has deve...

(Date:12/2/2009)...CHICAGO Results of a large-scale clinical trial p...ogical Society of North America (RSNA) provide the...reening ultrasound for women with dense breasts wh...ion, the study confirmed that MRI is highly sensit...d that annual screening with ultrasound in additio...

(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, Th...eutics - Market Forecasts to 2015, Competitive Ben..., http://www.reportlinker.com/p0166814/The-Futu...---Market-Forecasts-to-2015-Competitive-Benchmarki...

[0] Beneath the Short White Coat: A Medical Student Reveals All [0] Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today [0] LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer [0] Annual screening with breast ultrasound or MRI could benefit some women [0] Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

..., NEW YORK, March 23, 2008Research led by investi...MSKCC) has shown that therapeutic cloning, also kn...e used to treat Parkinsons disease in mice. The s...cloning or SCNT has been successfully used to trea...

...Music therapy can help reduce anxiety and improve ...ealthDay News) -- Almost everyone has used music a...nergized. But the discipline of music therapy take...in physical, psychological, social and cognitive d...

...Study with dogs shows devices much more than a mec...Y, March 21 (HealthDay News) -- In dogs with damag...rovements in tissue levels and the activity of a ...emical analysis of the biological effects a pacema...

...But it,s not too late to protect yourself and your...(HealthDay News) -- News from the diabetes front s... of the disease, fueled by obesity and sedentary l...adults and children, according to the American Dia...

..., (PHILADELPHIA) Scientists at the Center for Tra... in Philadelphia have shown that a specific signal... helping it to adapt during a heart attack. , The... or if it was actually causing more heart cells to...

...WASHINGTON, March 21 America,s Blood Centers,(ABC... community,independent blood centers, has teamed u... educate lawmakers about the importance of stem ce...laborate on emerging regulatory,issues, standards/...

Other Medicine News:Health News:Music as Medicine 2 Health News:Music as Medicine 3 Health News:Pacemakers Change Biology of the Heart 2 Health News:Diabetes' Toll Continues to Grow 2 Health News:Diabetes' Toll Continues to Grow 3 Health News:Diabetes' Toll Continues to Grow 4 Health News:Signaling protein helps limit damage in heart attack, Jefferson scientists show 2 Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 2 Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 3 Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 4

Therapeutic cloning treats Parkinson's disease in mice Music as Medicine Pacemakers Change Biology of the Heart Diabetes' Toll Continues to Grow Signaling protein helps limit damage in heart attack, Jefferson scientists show ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment

(Date:12/1/2009)..., VIENNA, Va., Dec. 1 CE... oncology company and a developer of vaccines and ...nfectious diseases, announced today that it has re...esearch Organization (CRO) to run CEL-SCI,s upcomi...ad and neck cancer with the Company,s lead product...

(Date:12/1/2009)..., MORRISVILLE, N.C., Dec. 1 nCo... investigation of devices for minimally-invasive t... initiation of a feasibility clinical trial design...ed surgical and catheter procedure, the convergent...ysmal atrial fibrillation (AF). This prospective,...

(Date:12/1/2009)..., MT. LAUREL, N.J., Dec. 1 /PRNewswire-FirstCall...vider of technology-enabled clinical documentation...ch tool from Primordial Design, Inc. has been inte...real-time speech recognition system. The solution ...of North America (RSNA) convention November 29 thr...

Breaking Medicine Technology:CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2 CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3 nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2 MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2 Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 1 Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 2 Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 3 Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 4 Molecule plays early role in nonsmoking lung cancer 52821 1 Molecule plays early role in nonsmoking lung cancer 52821 2 121 breeding tigers estimated to be found in Nepal 9374 1 121 breeding tigers estimated to be found in Nepal 9374 2

[0] CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine [0] nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure [0] MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology

... pivotal studies presented at the National Lipid ...ions, PARSIPPANY, N.J., May 30 Daiichi Sankyo, I...es of three pivotal studies,demonstrated that the ...on,diabetes treatment regimens can lower A1C in pa...ter. The analyses included all patients receiving,...

... Increasingly Important Factor When Selecting Trea...s - ABSTRACT No: 5110 (Poster 6... the,largest oncology meeting in the world, the Am...that the costs of managing side effects in patient... with sunitinib (Sutent(R)),are two to three times...

Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2 Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3 Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4 Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5 Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6 Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2 Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3

Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon

...r beam is delivered through an ultra thin flexible... freedom of movement when performing surgery. The...of handpieces. Handpieces are supplied with stand...d angled fiber guides with different lengths offer...

Reusable Components

VersaStep™ Reposable (Reusable Components - Standard Length)

VersaStep™ Reposable Short Single-Use Instruments

Medicine Products:

MedArt® 426 Reusable Components VersaStep™ Reposable (Reusable Components - Standard Length)VersaStep™ Reposable Short Single-Use Instruments

inVentiv Health Provides Updated Information on December 11th In...( SOMERSET N.J. Dec. 3 /- inVentiv ...),Health